A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
about
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicCharacterization of the canine mda-7 gene, transcripts and expression patterns.MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.The development of MDA-7/IL-24 as a cancer therapeuticEnhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).Gene Therapies for Cancer: Strategies, Challenges and Successes.Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic micemda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM.Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cellsHeat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma.MDA-7/IL-24 inhibits cell survival by inducing apoptosis in nasopharyngeal carcinoma.Arsenic in leukemia: a RSKy businessThe potential of virus-based gene therapies for treatment of metastatic kidney cancer.Cancer Terminator Viruses (CTV): A Better Solution for Viral-Based Therapy of Cancer.
P2860
Q27694606-3BB1A018-1D06-476F-B89C-6435E23A2B08Q34040220-CC655C6C-FB0A-4F36-940B-0803644C8D5AQ34041932-CF662225-7966-4A3D-AE17-DCEAC5EAB798Q34163896-76315F85-5DDC-4222-B3EE-B3B9BFCFB8C1Q35095082-7C2CB675-E030-4A80-8ECA-AA826485B498Q35186312-16D5F2A7-1B12-4EEA-87CB-7381A844B7E2Q36545638-6A6B1A8D-B457-45BC-B8D0-0DB2234026BAQ37014165-553180C4-52BE-4A53-B182-B2C58F7E879FQ37586906-F78E417A-D261-49E1-9820-B77B193036D7Q39058878-3AAA2DEB-11D2-4F2D-B52A-F760D28F48C1Q41570156-114091ED-1ACA-4137-A0B7-CAC2F68353C8Q41960709-A4AFEC5D-8BAF-44CE-A3EC-13B4D5326532Q45365447-C61F08C2-FDAC-4723-9DEC-40D7FCC49564Q47560447-9B1CEDCD-2E63-40B9-A526-5759C9F3C430
P2860
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@ast
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@en
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@nl
type
label
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@ast
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@en
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@nl
prefLabel
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@ast
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@en
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@nl
P2093
P2860
P50
P356
P1476
A serotype 5/3 adenovirus expr ...... rease ROS and ceramide levels.
@en
P2093
Adly Yacoub
Besim Ogretmen
Clint Mitchell
Hossein A Hamed
Igor P Dmitriev
Jeremy Allegood
Margaret A Park
Nichola Cruickshanks
Paul B Fisher
P2860
P304
P356
10.1124/MOL.110.069484
P577
2010-11-30T00:00:00Z